[1]
P. Farahani, M. Levine, K. Gaebel, and L. Thabane, “CLINICAL DATA GAP BETWEEN PHASE III CLINICAL TRIALS (PRE-MARKETING) AND PHASE IV (POST-MARKETING) STUDIES: EVALUATION OF ETANERCEPT IN RHEUMATOID ARTHRITIS”, J Popl Ther Clin Pharmacol, vol. 12, no. 3, Dec. 2018, Accessed: Nov. 19, 2024. [Online]. Available: https://mail.jptcp.com/index.php/jptcp/article/view/99